Year-End Report

GILBERT'S LLP for MYLAN LABORATORIES INC

Firm
Client
Income
$180,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES

Government Issues GOV

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Health Issues HCR

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES

Foreign Relations FOR

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Medicare/Medicaid MMM

Patent Reform and reform of legislation and regulations relating to the approval of drugs

LobbyistCovered position, as disclosed
NAWEL BAILEY N/A
TIM GILBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.